Reconstructed Human Small Intestine and Human Skin Models Microtissue Samples and Culture Media

The U.S. Food and Drug Administration (FDA) is seeking a contractor to provide Reconstructed Human Small Intestine and Human Skin Models Microtissue Samples and Culture Media. The contractor will be required to deliver multiple batches of microtissue samples and maintenance media on specific dates between August 24, 2026, and October 19, 2026. The microtissue samples must meet certain minimum specifications, including being derived from human donors and consisting of specific cell types. The contractor must also provide sufficient maintenance media for the culture of the microtissue samples. • The contract is for a firm-fixed price. • The contractor must ensure proper control and coordination of all deliverables to ensure they are on time. • The Government will review deliverables and notify the contractor of acceptance or non-acceptance within 10 business days of submission. • The contractor must comply with Section 508 accessibility standards for information and communication technology (ICT) supplies, products, platforms, information, documentation, and services support. • The contractor must submit an Accessibility Conformance Report (ACR) for each item not in compliance with 508 standards.